arrow
R

Ran Xu

Harvard Medical School
H指数:12
被引数:536

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Live-cell Pick-Seq (LiP-Seq): Interrogating ultra-rare mantle cell lymphoma persistent cells after CART19 therapy

活细胞Pick-Seq (LiP-Seq):CART19疗法后检测超罕见套细胞淋巴瘤持续性细胞

2026-03-230
OAAI
Modular PROTAC/IMiD Bifunctional Molecule Design for the Degradation of Synergistic Targets in the Treatment of Lymphoma

模块化PROTAC/IMiD双功能分子设计,用于在淋巴瘤治疗中协同靶点的降解

2025-10-140
PRE
DNA replication stress underpins the vulnerability to oxidative phosphorylation inhibition in colorectal cancer

DNA复制应激是结直肠癌易受氧化磷酸化抑制的基础

2025-01-140
OAAI
Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial
2024-11-150
OA
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial

Duvelisib联合romidepsin治疗复发/难治性T细胞淋巴瘤: 1b/2a期试验

2024-06-171
PRE
Targetable leukaemia dependency on noncanonical PI3Kγ signalling

靶向白血病对非规范PI3Kγ 信号的依赖性

Nature
IF48.5
2024-05-080
PRE
TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence
2023-09-205
OA
TP63 fusions drive enhancer rewiring, lymphomagenesis, and dependence on EZH2
2023-04-040
PRE